Skip to content

Control of hydration in hospital patients using an automated system.

An automated system for administering intravenous 5% dextrose to control the water balance of hospital patients, as measured by the serum sodium.

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12614001242617
Acronym
nil
Enrollment
30
Registered
2014-11-27
Start date
2014-12-14
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The aim is to develop a method to safely and accurately control the water state of patients in a minimally invasive and reliable fashion. The ultimate goal is to reduce complications of inappropriate fluid administration that result in patient harm. An intermediate step is to develop a model of water balance that can inform clinicians of current water state and hence recommend appropriate rates of intravenous 5% dextrose.

Interventions

1. A two-compartment model of the extracellular and intracellular fluids is created using patient anthropometrics and serum laboratory results. 2. The duration of infusion will take place from admission until discharge from the unit. 3. The device has two components. A sensor attached to the urinary collection system and a central processor. These devices communicate to determine a rate of infusion. 4. To ensure adherence, the nurse caring for the patient will monitor the intravenous line as pe

1. A two-compartment model of the extracellular and intracellular fluids is created using patient anthropometrics and serum laboratory results. 2. The duration of infusion will take place from admission until discharge from the unit. 3. The device has two components. A sensor attached to the urinary collection system and a central processor. These devices communicate to determine a rate of infusion. 4. To ensure adherence, the nurse caring for the patient will monitor the intravenous line as per standard clinical care. 5. The device will administer intravenous 5% dextrose at a variable dose, dependent on the need for water.

Sponsors

A/Prof William Geoffrey Parkin
Lead SponsorIndividual

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

The presence of a catheter and an intravenous cannula. The patient must be admitted to the intensive care unit to be eligible.

Exclusion criteria

Pregnancy

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026